Lately, Wojciak-Stothard and his colleagues have presented an organ-on-chip model of pulmonary arterial hypertension that identifies a BMPR2-SOX17-prostacyclin signaling axis [134]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.